Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Volkers

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Pharmacoepidemiology and Drug Safety|May 13, 2014
Risk of Guillain-Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in GermanyJürgen Prestel, Peter Volkers, Dirk Mentzer, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|October 22, 2011
Effect of Safety Measures on Bacterial Contamination Rates of Blood Components in GermanyGabriele Walther-Wenke, Walter Däubener, Margarethe Heiden, et al.
Scientific Reports|August 7, 2019
Structure functional insights into calcium binding during the activation of coagulation factor XIII ASneha Singh, Johannes Dodt, Peter Volkers, et al.
International Journal of Molecular Sciences|June 5, 2019
Identification of Potential Novel Interacting Partners for Coagulation Factor XIII B (FXIII-B) Subunit, a Protein Associated with a Rare Bleeding DisorderSneha Singh, Mohammad Suhail Akhter, Johannes Dodt, et al.
Biologicals : Journal of the International Association of Biological Standardization|February 27, 2007
Impact of vCJD on blood supplyRainer Seitz, Friedger von Auer, Johannes Blümel, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 9, 2019
Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studiesPeter Volkers, Kay-Martin Hanschmann, Thierry Calvez, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Pharmacoepidemiology and Drug Safety|May 13, 2014
Risk of Guillain-Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in GermanyJürgen Prestel, Peter Volkers, Dirk Mentzer, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|October 22, 2011
Effect of Safety Measures on Bacterial Contamination Rates of Blood Components in GermanyGabriele Walther-Wenke, Walter Däubener, Margarethe Heiden, et al.
Scientific Reports|August 7, 2019
Structure functional insights into calcium binding during the activation of coagulation factor XIII ASneha Singh, Johannes Dodt, Peter Volkers, et al.
International Journal of Molecular Sciences|June 5, 2019
Identification of Potential Novel Interacting Partners for Coagulation Factor XIII B (FXIII-B) Subunit, a Protein Associated with a Rare Bleeding DisorderSneha Singh, Mohammad Suhail Akhter, Johannes Dodt, et al.
Biologicals : Journal of the International Association of Biological Standardization|February 27, 2007
Impact of vCJD on blood supplyRainer Seitz, Friedger von Auer, Johannes Blümel, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 9, 2019
Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studiesPeter Volkers, Kay-Martin Hanschmann, Thierry Calvez, et al.
Pageof 2